Get Started

INO

NASD Inovio Pharmaceuticals, Inc.
Oct 23, 2026 · 1:43 AM ET EOD Market Closed

$0.8389 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.8389, $0.0810 below the day’s high of $0.9199

YTD change
-51.79%
vs 20-day SMA
-23.25%
vs 200-day SMA
-34.99%

Price ranges

Previous day
$0.7953 $1.0900
open $1.0700 close $0.7953
-$0.2747 (-25.67%)
Today
$0.7812 $0.9199
open $0.8029 now $0.8389
+$0.0360 (+4.48%)
Past week
$0.7953 $1.0900
from $0.9860 now $0.8389
-$0.1471 (-14.92%)
Past month
$0.7953 $1.2600
from $1.2500 now $0.8389
-$0.4111 (-32.89%)
This year
$0.5632 $2.0300
from $1.7400 now $0.8389
-$0.9011 (-51.79%)

Price & Performance

-0.30 (-26.41%) / 6M

$0.5917$0.9026$1.21$1.52Apr 22Jul 23Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.8% away from all-time highs of $405.4800
  • INO is down 52% since the beginning of the year
  • INO is down 62% over the past 12 months
  • INO is down 33% over the past 1 month
  • 20% of all INO investors are betting against INO

INO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -62.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.07
Earnings momentum +64.4% Quarterly EPS growth
Quarterly change +64.4%

Valuation

P/E ratio N/A
Enterprise value $36.2M
Beta 1.74

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$36.7M
Debt$8.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $86.7M

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
ROIV Roivant Sciences Ltd. $37.45 +1.77%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.